The global electrophoresis market is experiencing steady growth as demand for advanced molecular analysis, clinical diagnostics, and biotechnology research continues to increase. Electrophoresis is a laboratory technique used to separate and analyze charged biomolecules, including DNA, RNA, and proteins, by applying an electric field through a gel or another suitable medium. It plays an important role in genetic research, disease diagnosis, drug development, and pharmaceutical quality control.
The technique helps researchers understand the size, charge, purity, and composition of biological molecules. It is widely used in academic institutions, hospitals, diagnostic laboratories, pharmaceutical companies, and biotechnology organizations. Growing interest in personalized medicine, genomics, proteomics, and biopharmaceutical development is strengthening demand for accurate and efficient electrophoresis solutions.
Technological improvements are also changing laboratory workflows. Automated systems, capillary electrophoresis platforms, advanced reagents, and digital gel documentation tools are helping laboratories improve accuracy, productivity, and reproducibility. In addition, the adoption of safer precast gels is encouraging laboratories to reduce exposure to hazardous staining chemicals.
According to Kings Research, the global electrophoresis market was valued at USD 3,031.4 million in 2024. It is projected to grow from USD 3,179.0 million in 2025 to USD 4,530.1 million by 2032, registering a compound annual growth rate (CAGR) of 5.10% during the forecast period.
Key Market Growth Drivers
Rising Demand for Protein Analysis in Pharmaceutical Research
The growing use of electrophoresis for protein analysis is a major factor supporting market expansion. Protein separation and characterization are essential activities in drug discovery, biomarker identification, disease research, and biopharmaceutical manufacturing.
Pharmaceutical and biotechnology companies use electrophoresis to evaluate protein purity, monitor purification processes, analyze molecular weight, and study protein expression. These activities are particularly important in the development of biologics, including monoclonal antibodies and recombinant protein therapies.
As pharmaceutical research becomes more focused on complex biological products, laboratories require accurate analytical techniques that can deliver consistent results. Electrophoresis systems provide reliable separation and characterization capabilities, supporting their continued adoption across research and manufacturing environments.
In January 2024, Agilent Technologies introduced the ProteoAnalyzer, an automated parallel capillary electrophoresis platform designed for protein analysis. The system simplifies the analysis of complex protein mixtures and supports more efficient quality control workflows.
Increasing Demand for Molecular Diagnostics and Genetic Testing
The growing use of molecular diagnostics is creating additional opportunities for electrophoresis technologies. Healthcare providers increasingly rely on genetic and molecular testing to identify diseases, investigate inherited conditions, and support treatment decisions.
Electrophoresis helps separate DNA and RNA fragments, evaluate genetic material, and analyze biological samples. It is used in applications such as genetic screening, oncology research, infectious disease studies, and biomarker identification.
As healthcare systems move toward more precise diagnostic approaches, demand for reliable laboratory equipment is increasing. Improvements in diagnostic infrastructure and growing awareness of early disease detection are expected to support the use of electrophoresis in clinical laboratories.
Expanding Biotechnology and Life Sciences Research
Increasing investment in biotechnology and life sciences research is another important growth driver. Universities, research institutes, pharmaceutical companies, and government laboratories are expanding activities in genomics, proteomics, molecular biology, and drug discovery.
Electrophoresis remains an essential analytical technique in these fields because it enables the separation and examination of biological molecules. Researchers use it to study gene expression, identify proteins, assess sample quality, and validate experimental results.
The expansion of biopharmaceutical manufacturing is also increasing the need for dependable analytical tools. As companies develop more complex biological products, electrophoresis systems and reagents are becoming important components of research and quality control workflows.
Emerging Trends in the Electrophoresis Market
Growing Adoption of Precast Gels
The increasing adoption of precast gels is an important trend in the electrophoresis industry. Traditional gel preparation often requires manual handling, chemical mixing, and additional preparation time. These steps can introduce variability and increase laboratory workload.
Precast gels are manufactured in advance and are ready for use, helping laboratories simplify sample preparation and improve workflow consistency. Some products also use safer fluorescent dyes as alternatives to ethidium bromide, a widely used nucleic acid stain classified as a mutagen.
These ready-to-use solutions can reduce preparation time, improve reproducibility, and support safer laboratory practices. In August 2024, Biotium introduced precast agarose gels containing GelRed dye as an alternative to conventional ethidium bromide-based DNA visualization workflows.
Increasing Use of Capillary Electrophoresis
Capillary electrophoresis is gaining attention because it offers high separation efficiency, automation potential, and reduced sample requirements. The technique separates charged molecules inside narrow capillaries using an electric field.
It is used in protein characterization, genetic testing, pharmaceutical quality control, and biomolecular analysis. Compared with some traditional methods, capillary-based systems can support faster analysis and improved automation.
The growing need for detailed protein characterization is encouraging laboratories to adopt advanced capillary electrophoresis platforms. Specialized techniques such as capillary isoelectric focusing combined with mass spectrometry are also supporting more detailed analysis of protein charge variants.
Integration of Digital Software and Automated Documentation
Laboratories are increasingly adopting digital tools to improve electrophoresis data management and analysis. Gel documentation systems and specialized software help capture, visualize, store, and interpret experimental results.
Automated image analysis can reduce manual interpretation and improve consistency when comparing samples. Integration with laboratory information management systems can also support data traceability, reporting, and regulatory compliance.
Software platforms that provide automated data capture and high-throughput analysis are becoming increasingly important as laboratories manage larger volumes of molecular data.
Market Segmentation Analysis
The electrophoresis market is segmented by component, application, end user, and region.
By Component
Based on component, the market is divided into electrophoresis systems, electrophoresis reagents, gel documentation systems, and software.
The electrophoresis systems segment generated USD 1,636.6 million in revenue in 2024, according to the report's market highlights. Its strong position is supported by the growing use of advanced separation technologies in genomics, proteomics, diagnostics, and pharmaceutical research.
Electrophoresis systems include instruments used for gel-based and capillary-based separation processes. Growing demand for automated equipment and high-throughput molecular analysis is supporting product adoption.
Electrophoresis reagents are also essential because buffers, gels, stains, markers, and other consumables enable effective separation and visualization of biomolecules. Gel documentation systems and software support image capture, data interpretation, and laboratory reporting.
By Application
Based on application, the market is categorized into diagnostic, research, and quality control and process validation.
The diagnostic segment accounted for 42.17% of the market in 2024. Its position is supported by the increasing use of electrophoresis in disease detection, genetic testing, and molecular diagnostics.
Clinical laboratories use electrophoresis to analyze proteins and nucleic acids in biological samples. Protein electrophoresis, for example, can support the investigation of certain blood-related conditions, while DNA and RNA separation techniques are important in genetic and molecular research.
The diagnostic segment is projected to reach USD 1,890.2 million by 2032, supported by increasing demand for accurate testing and improved laboratory capabilities.
Research applications include genomics, proteomics, drug discovery, and molecular biology studies. Quality control and process validation applications are particularly relevant to pharmaceutical and biotechnology manufacturing, where consistent product quality and analytical reliability are essential.
By End User
Based on end user, the market includes academic institutions, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research organizations, and others.
Academic institutions represent an important end-user group because electrophoresis is widely used in university laboratories and scientific training programs. The segment is projected to reach USD 1,273.5 million by 2032, supported by investments in life sciences education, laboratory infrastructure, and research activities.
Hospitals and diagnostic centers use electrophoresis for clinical testing and disease investigation. Pharmaceutical and biotechnology companies depend on these technologies for drug discovery, protein characterization, and manufacturing quality control.
Research organizations also contribute to demand through work in molecular biology, genetic analysis, and biomedical innovation.
Regional Analysis
The global electrophoresis market is studied across North America, Europe, Asia Pacific, the Middle East and Africa, and South America.
North America
North America dominated the global market in 2024, accounting for 34.09% of revenue, equivalent to USD 1,033.3 million. The region benefits from advanced healthcare infrastructure, substantial pharmaceutical research investment, and a well-established biotechnology industry.
The United States and Canada have numerous academic institutions, clinical laboratories, and pharmaceutical companies that use electrophoresis for molecular research and diagnostics. Strong investment in genomics, proteomics, and personalized medicine is supporting demand for advanced analytical systems.
In April 2025, Roche announced a planned investment of USD 50 billion in diagnostics and pharmaceuticals in the United States over five years. The investment includes new research and development centers and expanded manufacturing facilities, reflecting continued development across the broader life sciences sector.
Asia Pacific
Asia Pacific is expected to be the fastest-growing regional market, with a projected CAGR of 6.07% through 2032. Increasing healthcare investment, expanding biotechnology research, and improvements in diagnostic infrastructure are supporting regional growth.
China, Japan, India, South Korea, and Australia are important markets due to their growing pharmaceutical industries and research capabilities. Collaboration between research institutions and diagnostic companies is also encouraging the development of advanced genetic testing technologies.
In February 2024, Hitachi High-Tech Corporation collaborated with Sysmex Corporation to develop genetic testing systems based on capillary electrophoresis sequencers. The initiative aims to support efficient and cost-effective genetic testing for clinical applications.
Europe
Europe represents an established market supported by pharmaceutical research, biotechnology development, and advanced clinical laboratory infrastructure. Countries such as Germany, the United Kingdom, France, and Italy have strong life sciences industries that use electrophoresis in drug development, diagnostics, and quality control.
The region's emphasis on research standards, laboratory safety, and product quality is encouraging the adoption of automated systems and advanced analytical technologies. Continued investment in biopharmaceutical development is expected to support demand.
Middle East, Africa, and South America
The Middle East and Africa offer growth opportunities as healthcare infrastructure improves and governments invest in diagnostic laboratories and medical research facilities. Increasing access to advanced testing technologies is expected to support gradual adoption.
In South America, pharmaceutical manufacturing, academic research, and clinical diagnostic services are contributing to market development. Brazil and Argentina are among the important markets where improvements in laboratory capabilities can create additional opportunities.
Challenges in the Electrophoresis Market
High Equipment and Installation Costs
The high cost of advanced electrophoresis systems and imaging equipment remains a significant challenge. Automated instruments, capillary electrophoresis platforms, and specialized documentation systems require substantial investment.
Smaller laboratories, academic institutions, and healthcare facilities with limited budgets may find it difficult to adopt newer technologies. As a result, some organizations continue using older equipment, which may affect analytical efficiency and testing capacity.
Manufacturers are addressing this challenge by introducing compact and modular systems that provide essential functionality at more accessible prices. Leasing arrangements and flexible financing options can also help laboratories manage equipment expenditure.
Need for Skilled Laboratory Professionals
Operating advanced electrophoresis systems and interpreting complex molecular results require appropriate technical expertise. Laboratory professionals must understand sample preparation, separation conditions, staining procedures, instrument calibration, and result interpretation.
A shortage of trained personnel can affect laboratory productivity and limit the adoption of advanced systems. Training programs, automated workflows, and user-friendly software are helping address this issue by simplifying equipment operation and reducing manual tasks.
Competitive Landscape
The electrophoresis market includes established laboratory equipment manufacturers, biotechnology suppliers, and specialized analytical technology companies. Competition is influenced by product performance, automation capabilities, analytical accuracy, reagent quality, and customer support.
Companies are investing in advanced software platforms, automated data capture, improved gel documentation, and high-throughput analysis. Strategic collaborations and product launches are also helping manufacturers expand their market presence.
Major companies operating in the market include UVItec, iGene Labserve, Edvotek Inc., MAESTROGEN INC., Kaneka Eurogentec S.A., Thistle Scientific Ltd., SID Group, Vilber, Bio-Rad Laboratories, Inc., Clinx Science Instruments Co., Ltd., Hoefer Inc., Azure Biosystems Inc., GeneBio Systems, Inc., Thermo Fisher Scientific Inc., and Sartorius AG.
In June 2024, CMP Scientific launched the BioSummit CVA system, a platform designed for charge variant analysis of recombinant protein therapeutics. The product supports detailed characterization of protein-based medicines.
In January 2025, Biotium introduced its EMBER Ultra Gel Kits for RNA and DNA electrophoresis. The kits feature precast agarose and loading dye to simplify nucleic acid detection workflows.
Future Opportunities
The electrophoresis market offers opportunities through continued developments in precision diagnostics, biopharmaceutical manufacturing, and molecular research. Growing demand for genetic testing and protein characterization is expected to encourage laboratories to upgrade their analytical capabilities.
Automation and digital integration are likely to become increasingly important. Systems that combine electrophoresis instruments, image analysis, and laboratory software can improve productivity and support consistent results.
The expansion of biotechnology research in emerging economies also offers growth potential. As academic institutions, hospitals, and pharmaceutical companies invest in modern laboratory infrastructure, demand for electrophoresis systems and consumables is expected to increase.
Safer laboratory products, including precast gels and improved staining technologies, may further support adoption by reducing manual preparation and chemical handling requirements.
Conclusion
The global electrophoresis market is expected to expand steadily through 2032, supported by rising demand for molecular diagnostics, protein analysis, biotechnology research, and pharmaceutical quality control. The market is projected to reach USD 4,530.1 million by 2032, growing at a CAGR of 5.10% from 2025 to 2032.
North America currently holds the largest regional share, while Asia Pacific is expected to record the fastest growth. Electrophoresis systems and diagnostic applications represent important areas of market demand. Meanwhile, capillary electrophoresis, automated documentation, and safer precast gels are influencing the industry's development.
You must be logged in to post a comment.